Key F Inancial Inc Palatin Technologies Inc Transaction History

Key F Inancial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$0.27 - $0.5 $1,350 - $2,500	-5,000 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$0.38 - $0.78 $1,900 - $3,900	5,000 New	5,000 $3,000
Q2 2020 Aug 07, 2020	SELL	$0.41 - $0.73 $2,050 - $3,650	-5,000 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$0.36 - $0.79 $1,800 - $3,950	5,000 New	5,000 $2,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $17.5M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

Stay updated on Key F Inancial Inc with notifications on news.